Dipeptidyl peptidase-4 inhibitors and the risks of autoimmune diseases in type 2 diabetes mellitus patients in Taiwan: a nationwide population-based cohort study

Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus

Benjamin M. Scirica, Deepak L. Bhatt, Eugene Braunwald et al. · New England Journal of Medicine · 2013 · 3.5K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes

Jennifer B. Green, M. Angelyn Bethel, Paul W. Armstrong et al. · New England Journal of Medicine · 2015 · 2.6K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC

V. Stalin Raj, Huihui Mou, Saskia L. Smits et al. · Nature · 2013 · 2.1K citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +10

Taiwan’s New National Health Insurance Program: Genesis And Experience So Far

Tsung-Mei Cheng · Health Affairs · 2003 · 708 citations

Public Affairs, Health Policy, Insurance +15

Accuracy of diabetes diagnosis in health insurance claims data in Taiwan.

Cheng-Ching Lin, Mei‐Shu Lai, Ci-Yong Syu et al. · PubMed · 2005 · 515 citations

Business, Insurance, Diabetology +10